Purple Biotech (PPBT) Shares Outstanding (Diluted Average) (2022 - 2025)
Purple Biotech (PPBT) reported Shares Outstanding (Diluted Average) of $480053.0 for Q4 2025, down 70.72% year-over-year from $1.6 million in Q4 2024, and down 70.72% quarter-over-quarter from $1.6 million in Q4 2024.
Purple Biotech (PPBT) Shares Outstanding (Diluted Average) (2022 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $480053.0 in Q4 2025.
- Shares Outstanding (Diluted Average) for Q4 2025 came in at $480053.0, down 70.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $480053.0 (down 70.72% YoY), and the FY2025 annual result was $480053.0, down 70.72% from the prior year.
- Shares Outstanding (Diluted Average) eased to $480053.0 in Q4 2025 per PPBT's latest filing, from $1.6 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $1.6 million in Q4 2024 and troughed at $480053.0 in Q4 2025.
- A 4-year average of $1.0 million and a median of $1.0 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) surged 48.17% in 2024, then plunged 70.72% in 2025.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $904054.0 in 2022, then grew by 22.41% to $1.1 million in 2023, then soared by 48.17% to $1.6 million in 2024, then sank by 70.72% to $480053.0 in 2025.
- Business Quant data shows PPBT's Shares Outstanding (Diluted Average) at $480053.0 in Q4 2025, $1.6 million in Q4 2024, and $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 92.44 Mn |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 480,053.00 |
| Dec 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 904,054.00 |